Exchange: NASDAQ·Updated 07:30 PM EDT
News
all
press releases
If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 5.32% on an annualized basis producing an average annual return of 14.56%. Currently, Vertex Pharmaceuticals has a marketread more...
Benzinga
More News
Vertex Pharmaceuticals: A Biotech Cash Cow With Pipeline Upside?
Explore the exciting world of Vertex Pharmaceuticals (NASDAQ: VRTX) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were...
Nasdaq News: Markets
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
Key PointsVertex Pharmaceuticals' business could be in trouble if it faces competition in its core market...
Nasdaq News: Markets
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More
Key PointsVertex Pharmaceuticals appears likely to continue to dominate its core therapeutic area...
Nasdaq News: Markets
Vertex (VERX) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Vertex (VRTX) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?
Key PointsVertex Pharmaceuticals could face competition in its most important market by far...
Nasdaq News: Markets
3 Reasons Why Growth Investors Shouldn't Overlook Vertex (VERX)
Vertex (VERX) could produce exceptional returns because of its solid growth attributes.
Zacks
Why Vertex Pharmaceuticals Stock Ticked Higher on Tuesday
Key PointsIts sales rose at a double-digit rate; net profit growth was more modest...
Nasdaq News: Markets
Compared to Estimates, Vertex (VERX) Q2 Earnings: A Look at Key Metrics
The headline numbers for Vertex (VERX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks

Advertisement|Remove ads.